Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,904 | 600 | 67.0% |
| Unspecified | $4,500 | 6 | 30.4% |
| Debt forgiveness | $328.72 | 2 | 2.2% |
| Travel and Lodging | $20.09 | 1 | 0.1% |
| Education | $18.31 | 3 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.16 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $4,517 | 7 | $0 (2020) |
| Amgen Inc. | $785.21 | 41 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $709.38 | 41 | $0 (2022) |
| Eisai Inc. | $658.09 | 38 | $0 (2023) |
| Novo Nordisk Inc | $521.94 | 37 | $0 (2022) |
| Lilly USA, LLC | $457.95 | 33 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $408.30 | 22 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $383.24 | 28 | $0 (2021) |
| PFIZER INC. | $374.02 | 29 | $0 (2023) |
| Merck Sharp & Dohme LLC | $367.47 | 32 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $906.71 | 45 | Takeda Pharmaceuticals U.S.A., Inc. ($131.70) |
| 2022 | $1,120 | 66 | SK Life Science, Inc. ($125.74) |
| 2021 | $1,835 | 95 | DJO, LLC ($328.72) |
| 2020 | $3,417 | 59 | ACADIA Pharmaceuticals Inc ($2,500) |
| 2019 | $3,728 | 110 | ACADIA Pharmaceuticals Inc ($2,000) |
| 2018 | $2,114 | 125 | Amgen Inc. ($251.17) |
| 2017 | $1,665 | 113 | AstraZeneca Pharmaceuticals LP ($200.15) |
All Payment Transactions
613 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Rare Disease | ||||||
| 09/27/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.93 | General |
| Category: SLEEP MEDICINE | ||||||
| 09/26/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $18.11 | General |
| Category: Neurology | ||||||
| 09/22/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $25.28 | General |
| 09/19/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Neuropsychiatry | ||||||
| 09/15/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.59 | General |
| 09/06/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Immunology | ||||||
| 09/05/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROLOGY | ||||||
| 08/24/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: SLEEP MEDICINE | ||||||
| 08/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $24.11 | General |
| 08/23/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Neuropsychiatry | ||||||
| 08/15/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/28/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Neurology | ||||||
| 07/26/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: NEUROLOGY | ||||||
| 07/20/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: PAIN | ||||||
| 07/19/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.41 | General |
| 07/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $21.66 | General |
| 07/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Rare Disease | ||||||
| 06/28/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROLOGY | ||||||
| 06/22/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: PAIN | ||||||
| 06/20/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Urology | ||||||
| 06/19/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACA 16-cAC-0001 | ACADIA Pharmaceuticals Inc | $4,500 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 331 | 461 | $74,082 | $27,065 |
| 2022 | 29 | 1,522 | 2,471 | $364,443 | $146,772 |
| 2021 | 28 | 1,960 | 3,001 | $408,864 | $172,276 |
| 2020 | 26 | 1,721 | 2,910 | $412,462 | $155,365 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 86 | $21,612 | $7,291 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $8,678 | $4,831 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 44 | $7,612 | $2,553 | 33.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 16 | 70 | $7,913 | $2,353 | 29.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 29 | 29 | $2,900 | $2,198 | 75.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $7,619 | $2,045 | 26.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 16 | 58 | $7,630 | $1,819 | 23.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 22 | 22 | $3,580 | $1,420 | 39.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 21 | 25 | $2,132 | $1,014 | 47.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,680 | $875.84 | 52.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 28 | 28 | $2,250 | $522.20 | 23.2% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 11 | $476.00 | $143.66 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 327 | $74,934 | $26,475 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 170 | 170 | $34,000 | $22,846 | 67.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 322 | $48,944 | $18,967 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 136 | $42,024 | $16,847 | 40.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 25 | 203 | $32,303 | $8,624 | 26.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 105 | 111 | $13,575 | $7,574 | 55.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 27 | 182 | $23,931 | $7,073 | 29.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 69 | 69 | $10,350 | $5,414 | 52.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 76 | 109 | $7,085 | $4,461 | 63.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 15 | 15 | $5,250 | $4,150 | 79.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 18 | $6,750 | $3,929 | 58.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 108 | 114 | $5,700 | $3,460 | 60.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 168 | 168 | $21,840 | $3,186 | 14.6% |
About Dr. Rafael Pardo, MD
Dr. Rafael Pardo, MD is a Family Medicine healthcare provider based in Baytown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578565826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rafael Pardo, MD has received a total of $14,786 in payments from pharmaceutical and medical device companies, with $906.71 received in 2023. These payments were reported across 613 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($9,904).
As a Medicare-enrolled provider, Pardo has provided services to 5,534 Medicare beneficiaries, totaling 8,843 services with total Medicare billing of $501,479. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Baytown, TX
- Active Since 06/01/2005
- Last Updated 06/30/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578565826
Products in Payments
- NUPLAZID (Drug) $4,517
- Fycompa (Drug) $605.23
- FARXIGA (Drug) $451.93
- Prolia (Biological) $386.03
- INGREZZA (Drug) $321.66
- Vascepa (Drug) $311.24
- Aimovig (Biological) $291.01
- XARELTO (Drug) $245.07
- AJOVY (Drug) $213.59
- Horizant (Drug) $201.60
- Victoza (Drug) $191.46
- BYDUREON (Drug) $180.17
- NURTEC ODT (Drug) $166.54
- AIMOVIG (Biological) $162.56
- Ozempic (Drug) $157.20
- JARDIANCE (Drug) $153.11
- Aliqopa (Drug) $144.23
- BOTOX (Biological) $142.93
- TRULICITY (Drug) $140.11
- NEXLETOL (Drug) $131.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Baytown
Dr. Fariborz Nazari-Adli, M.d, M.D
Family Medicine — Payments: $27,043
Dr. Kory Guidry, M.d, M.D
Family Medicine — Payments: $17,799
Mani Khoshnejad, M.d, M.D
Family Medicine — Payments: $15,421
Gregory Terry, M.d.,, M.D.,
Family Medicine — Payments: $13,382
Dr. Atul Sachdev, Md Pa, MD PA
Family Medicine — Payments: $10,200
Dr. Adetokunbo Akinyeye, M.d, M.D
Family Medicine — Payments: $9,761